The Co-Delivery of Oxaliplatin Abrogates the Immunogenic Response to PEGylated siRNA-Lipoplex
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Co-Delivery of Oxaliplatin Abrogates the Immunogenic Response to PEGylated siRNA-Lipoplex
Authors
Keywords
anti-PEG IgM, cytokines, PEGylated siRNA cationic liposome (lipoplex), short interfering RNA (siRNA), β-galctosidase
Journal
PHARMACEUTICAL RESEARCH
Volume 30, Issue 9, Pages 2344-2354
Publisher
Springer Nature
Online
2013-05-14
DOI
10.1007/s11095-013-1078-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Supramolecular assemblies in functional siRNA delivery: Where do we stand?
- (2011) Hamidreza M. Aliabadi et al. BIOMATERIALS
- The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
- (2011) Jurjen Tel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA
- (2011) Tatsuaki Tagami et al. JOURNAL OF CONTROLLED RELEASE
- Platinum Interference with siRNA Non-seed Regions Fine-Tunes Silencing Capacity
- (2011) Hanna K. Hedman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Double-modulation Strategy in Cancer Treatment With a Chemotherapeutic Agent and siRNA
- (2011) Kazuya Nakamura et al. MOLECULAR THERAPY
- Polymers in Small-Interfering RNA Delivery
- (2011) Kaushik Singha et al. Nucleic Acid Therapeutics
- Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
- (2010) T Kato et al. GENE THERAPY
- Alternative Activation of Macrophages: Mechanism and Functions
- (2010) Siamon Gordon et al. IMMUNITY
- Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase
- (2010) JingXia Cui et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Novel RNA-based Strategies for Therapeutic Gene Silencing
- (2010) Christopher R Sibley et al. MOLECULAR THERAPY
- Lipidic Systems for In Vivo siRNA Delivery
- (2009) Sherry Y. Wu et al. AAPS Journal
- Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production
- (2009) Tatsuaki Tagami et al. JOURNAL OF CONTROLLED RELEASE
- siRNA and Innate Immunity
- (2009) Marjorie Robbins et al. OLIGONUCLEOTIDES
- RNAi-Mediated Silencing of Nuclear Factor Erythroid-2-Related Factor 2 Gene Expression in Non-Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy
- (2008) A. Singh et al. CANCER RESEARCH
- Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
- (2008) Maha Saad et al. Nanomedicine
- Unique Properties of DNA Interstrand Cross-Links of Antitumor Oxaliplatin and the Effect of Chirality of the Carrier Ligand
- (2007) Jana Kasparkova et al. CHEMISTRY-A EUROPEAN JOURNAL
- Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
- (2007) Tatsuhiro Ishida et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started